The relationship between MRI and PET changes and cognitive disturbances in MS

Area of Science:

• Neuroimaging
• Neurology
• Biochemistry

Background:

• Cognitive dysfunction impacts roughly 50% of multiple sclerosis (MS) patients.
• Conventional MRI metrics (lesion load, atrophy) show weak correlations with cognitive impairment.
• Subtle brain abnormalities in normal-appearing white matter (NAWM) and grey matter may underlie cognitive deficits.

Purpose of the Study:

• To explore advanced imaging techniques for better correlation with cognitive dysfunction in MS.
• To investigate MR spectroscopy (MRS) and PET for detecting axonal dysfunction in MS lesions and normal-appearing brain tissue.

Main Methods:

• Utilized multi-slice echo planar spectroscopic imaging (EPSI) for MR spectroscopy (MRS).
• Employed Positron Emission Tomography (PET) to measure cortical cerebral metabolic rate of glucose.
• Measured global N-acetylaspartate (NAA) using multi-slice EPSI.

Main Results:

• Multi-slice EPSI offers a novel, non-invasive method to assess global neuronal capacity.
• MRS and PET can detect abnormalities in both MS lesions and normal-appearing brain matter.
• These advanced techniques show promise in correlating with cognitive dysfunction in MS.

Conclusions:

• Advanced imaging like MRS and PET are crucial for understanding the full scope of brain pathology in MS.
• Global NAA measurements via multi-slice EPSI represent a promising tool for assessing neuronal health.
• Improved imaging methods are needed to accurately link brain changes to cognitive decline in MS patients.